nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case of large cell carcinoma of the lung arising from the inner surface of a pulmonary bulla and complicated by hematoma
|
|
|
1996 |
14 |
1 |
p. 163- 1 p. |
artikel |
2 |
A case of postoperative hyponatremia caused by Sheehan syndrome associated with lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 158- 1 p. |
artikel |
3 |
Accelerated induction therapy and resection for poor prognostic stage III non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 177-178 2 p. |
artikel |
4 |
Acquired TGFβ 1 sensitivity and TGFβ 1 expression in cell lines established from a single small cell lung cancer patient during clinical progression
|
Nørgaard, Peter |
|
1996 |
14 |
1 |
p. 63-73 11 p. |
artikel |
5 |
Adjuvant and neo-adjuvant chemotherapy in non-small cell carcinoma
|
|
|
1996 |
14 |
1 |
p. 175- 1 p. |
artikel |
6 |
Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma: A randomized trial of 267 patients
|
|
|
1996 |
14 |
1 |
p. 176- 1 p. |
artikel |
7 |
A hereditary genetic marker closely associated with microsatellite instability in lung cancer
|
|
|
1996 |
14 |
1 |
p. 153- 1 p. |
artikel |
8 |
Airway stents: Present and future
|
|
|
1996 |
14 |
1 |
p. 164- 1 p. |
artikel |
9 |
A long-term survivor of the squamous cell lung cancer with chest-wall invasion effectively treated by irradiation and hyperthermia
|
|
|
1996 |
14 |
1 |
p. 175- 1 p. |
artikel |
10 |
Altered expression of the p50 subunit of the NF-kappaB transcription factor complex in non-small cell lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 153- 1 p. |
artikel |
11 |
Ambulatory low-toxicity chemotherapy in non-small-cell lung carcinoma by continuous 28-day infusion of alternating cisplatin and 5-fluorouracil
|
|
|
1996 |
14 |
1 |
p. 167- 1 p. |
artikel |
12 |
Anemia and changes in serum erythropoietin levels during chemotherapy for lung cancer
|
|
|
1996 |
14 |
1 |
p. 169- 1 p. |
artikel |
13 |
A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: A University of Colorado Cancer Center study
|
|
|
1996 |
14 |
1 |
p. 172- 1 p. |
artikel |
14 |
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer
|
|
|
1996 |
14 |
1 |
p. 170-171 2 p. |
artikel |
15 |
A proposed new International TNM Staging System for malignant pleural mesothelioma from the International Mesothelioma Interest Group
|
Rusch, Valerie W. |
|
1996 |
14 |
1 |
p. 1-12 12 p. |
artikel |
16 |
A prospective randomised study in limited disease small cell carcinoma—doxorubicin and vincristine plus either cyclophosphamide or etoposide
|
|
|
1996 |
14 |
1 |
p. 167- 1 p. |
artikel |
17 |
Are bilobectomies acceptable procedures?
|
|
|
1996 |
14 |
1 |
p. 163-164 2 p. |
artikel |
18 |
A resected case of double primary lung cancers, each with coexistent metastasis in the same mediastinal lymph node
|
|
|
1996 |
14 |
1 |
p. 164- 1 p. |
artikel |
19 |
Association of body mass index and body fat distribution with risk of lung cancer in older women
|
|
|
1996 |
14 |
1 |
p. 152- 1 p. |
artikel |
20 |
Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation
|
|
|
1996 |
14 |
1 |
p. 151- 1 p. |
artikel |
21 |
Axillary lymph node metastases of bronchogenic carcinoma
|
|
|
1996 |
14 |
1 |
p. 162-163 2 p. |
artikel |
22 |
Binding capacities of two immunomodulatory lectins, carrier-immobilized glycoligands and steroid hormones in lung cancer and the concentration of nitrite/nitrate in pleural effusions
|
Timoshenko, A.V. |
|
1996 |
14 |
1 |
p. 75-84 10 p. |
artikel |
23 |
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide
|
|
|
1996 |
14 |
1 |
p. 169- 1 p. |
artikel |
24 |
Bronchial artery infusion of chemotherapeutic agents plus external irradiation in the treatment of advanced lung cancer —A report of 37 cases
|
|
|
1996 |
14 |
1 |
p. 176- 1 p. |
artikel |
25 |
Bronchioloalveolar carcinoma
|
|
|
1996 |
14 |
1 |
p. 178- 1 p. |
artikel |
26 |
Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: A preliminary report
|
|
|
1996 |
14 |
1 |
p. 177- 1 p. |
artikel |
27 |
Chalcones, myo-inositol and other novel inhibitors of pulmonary carcinogenesis
|
|
|
1996 |
14 |
1 |
p. 152- 1 p. |
artikel |
28 |
Changes of ventilatory and respiratory function of the lungs after pneumonectomy
|
|
|
1996 |
14 |
1 |
p. 165-166 2 p. |
artikel |
29 |
Characteristics of non-small cell lung cancer 3 cm or less in diameter
|
|
|
1996 |
14 |
1 |
p. 162- 1 p. |
artikel |
30 |
Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background
|
|
|
1996 |
14 |
1 |
p. 152-153 2 p. |
artikel |
31 |
Chemoradiation in advanced nonsmall cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 175- 1 p. |
artikel |
32 |
Chemotherapy in non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 168- 1 p. |
artikel |
33 |
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
|
|
|
1996 |
14 |
1 |
p. 167-168 2 p. |
artikel |
34 |
Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma
|
|
|
1996 |
14 |
1 |
p. 158-159 2 p. |
artikel |
35 |
Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription
|
|
|
1996 |
14 |
1 |
p. 153-154 2 p. |
artikel |
36 |
Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA B non-small cell carcinoma of the lung
|
|
|
1996 |
14 |
1 |
p. 177- 1 p. |
artikel |
37 |
Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: A phase I and pharmacokinetic study
|
|
|
1996 |
14 |
1 |
p. 177- 1 p. |
artikel |
38 |
Cost analysis of hospital treatment—two chemotherapic regimens for non-surgical non-small cell lung cancer
|
Vergnenègre, A |
|
1996 |
14 |
1 |
p. 31-44 14 p. |
artikel |
39 |
Cost utility of chemotherapy and best supportive care in non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 179- 1 p. |
artikel |
40 |
Cytotoxicity of a novel indoloquinone EO9 in hypoxic nonsmall cell lung cancer cell lines
|
|
|
1996 |
14 |
1 |
p. 168- 1 p. |
artikel |
41 |
Detection of circulating cancer cells by RT-PCR in patients with resectable lung cancer
|
|
|
1996 |
14 |
1 |
p. 159- 1 p. |
artikel |
42 |
Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 157- 1 p. |
artikel |
43 |
Diagnosing the indeterminate pulmonary nodule: percutaneous biopsy versus thoracoscopy
|
|
|
1996 |
14 |
1 |
p. 157- 1 p. |
artikel |
44 |
Dissemination in athymic nude mice of lacZ transfected small cell lung cancer cells identified by X-gal staining
|
|
|
1996 |
14 |
1 |
p. 153- 1 p. |
artikel |
45 |
Distribution of the different histologic types of bronchogenic carcinoma
|
|
|
1996 |
14 |
1 |
p. 155- 1 p. |
artikel |
46 |
Docetaxel in stage III and IV non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 166- 1 p. |
artikel |
47 |
Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 171- 1 p. |
artikel |
48 |
Early alternating chemotheapy and radiotherapy schedule in limited disease stage small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 175- 1 p. |
artikel |
49 |
Economic value of gemcitabine compared to cisplatin and etoposide in non-small cell lung cancer
|
Copley-Merriman, Catherine |
|
1996 |
14 |
1 |
p. 45-61 17 p. |
artikel |
50 |
Editorial Board
|
|
|
1996 |
14 |
1 |
p. IFC- 1 p. |
artikel |
51 |
Efficacy and toxicity of mitomycin, ifosfamide, and cisplatin (MIP) in patients with inoperable non-small cell lung cancer
|
Urban, Thierry |
|
1996 |
14 |
1 |
p. 109-117 9 p. |
artikel |
52 |
Electron microscopic morphometry of the nucleus and its clinical significance in adenocarcinoma of the lung
|
|
|
1996 |
14 |
1 |
p. 155-156 2 p. |
artikel |
53 |
Endobronchial brachytherapy
|
|
|
1996 |
14 |
1 |
p. 174- 1 p. |
artikel |
54 |
Enlarged mediastinal nodes as markers of involvement by NSCLC
|
|
|
1996 |
14 |
1 |
p. 162- 1 p. |
artikel |
55 |
Establishment of human lung adenocarcinoma cisplatin-resistant cell line A549 DDP and the mechanism of it's drug resistance
|
|
|
1996 |
14 |
1 |
p. 169-170 2 p. |
artikel |
56 |
Etoposide administered orally in the treatment of lung cancer
|
|
|
1996 |
14 |
1 |
p. 170- 1 p. |
artikel |
57 |
Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18] fluoromisonidazole positron emission tomography
|
|
|
1996 |
14 |
1 |
p. 173- 1 p. |
artikel |
58 |
Evaluation of the response to chemotherapy in patients affected with small cell lung cancer using discriminant analysis: A preliminary report
|
|
|
1996 |
14 |
1 |
p. 168-169 2 p. |
artikel |
59 |
Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer
|
|
|
1996 |
14 |
1 |
p. 159- 1 p. |
artikel |
60 |
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium
|
Zhou, J. |
|
1996 |
14 |
1 |
p. 85-97 13 p. |
artikel |
61 |
Expression of α3β1 integrin receptor and its ligands in human lung tumors
|
|
|
1996 |
14 |
1 |
p. 156- 1 p. |
artikel |
62 |
Four-day paclitaxel infusion with cisplatin for patients with lung cancer
|
|
|
1996 |
14 |
1 |
p. 170- 1 p. |
artikel |
63 |
Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines
|
|
|
1996 |
14 |
1 |
p. 154- 1 p. |
artikel |
64 |
Gene therapy for lung cancer
|
|
|
1996 |
14 |
1 |
p. 179- 1 p. |
artikel |
65 |
Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis
|
|
|
1996 |
14 |
1 |
p. 150- 1 p. |
artikel |
66 |
Giant cell carcinoma of the lung
|
|
|
1996 |
14 |
1 |
p. 149- 1 p. |
artikel |
67 |
Good results of surgical treatment of elderly patients with stage I lung cancer
|
|
|
1996 |
14 |
1 |
p. 165- 1 p. |
artikel |
68 |
High cell proliferation activity determined by DNA flow cytometry and prognosis in epidermoid lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 154- 1 p. |
artikel |
69 |
Higher lung cancer risk for younger African-Americans with the Pro Pro p53 genotype
|
|
|
1996 |
14 |
1 |
p. 151- 1 p. |
artikel |
70 |
Histogenesis of adenosquamous bronchogenic carcinoma
|
|
|
1996 |
14 |
1 |
p. 155- 1 p. |
artikel |
71 |
Human non-small cell lung cancer cells express a type 2 cytokine pattern
|
|
|
1996 |
14 |
1 |
p. 154- 1 p. |
artikel |
72 |
Hypofractionated irradiation for inoperable non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 174- 1 p. |
artikel |
73 |
IASLC calendar
|
|
|
1996 |
14 |
1 |
p. 147-148 2 p. |
artikel |
74 |
Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
|
|
|
1996 |
14 |
1 |
p. 149- 1 p. |
artikel |
75 |
Imaging and staging of small-cell lung cancer: Is there a future role for octreotide scintigraphy?
|
|
|
1996 |
14 |
1 |
p. 158- 1 p. |
artikel |
76 |
Influence of heparin thromboprophylaxis on plasma leucocyte elastase levels following lobectomy for lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 164- 1 p. |
artikel |
77 |
Insulin like growth factor (IGF) and IGF binding proteins in growth hormone dysregulation and abnormal glucose tolerance in small cell lung cancer patients
|
|
|
1996 |
14 |
1 |
p. 159-160 2 p. |
artikel |
78 |
Intensive chemotherapy with autologous bone marrow transplantation for advanced lung cancer
|
|
|
1996 |
14 |
1 |
p. 169- 1 p. |
artikel |
79 |
Is there a role for chemotherapy of non-small cell lung cancer?
|
|
|
1996 |
14 |
1 |
p. 168- 1 p. |
artikel |
80 |
Long-term survival after removal of a single brain metastasis from lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 160-161 2 p. |
artikel |
81 |
Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung
|
|
|
1996 |
14 |
1 |
p. 173- 1 p. |
artikel |
82 |
Lung cancer
|
Sculier, J.-P. |
|
1996 |
14 |
1 |
p. 145-146 2 p. |
artikel |
83 |
Lung cancer and mutations at the polymorphic NAT2 gene locus
|
|
|
1996 |
14 |
1 |
p. 154-155 2 p. |
artikel |
84 |
Management (chemotherapy/best supportive care) of advanced-stage non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 170- 1 p. |
artikel |
85 |
Measurement of serum pro-gastrin-releasing peptide as an indicator for monitoring therapeutic effects in patients with small cell lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 162- 1 p. |
artikel |
86 |
Mediastinal staging of non-small-cell lung cancer: Computed tomography and cervical mediastinoscopy
|
|
|
1996 |
14 |
1 |
p. 157- 1 p. |
artikel |
87 |
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 158- 1 p. |
artikel |
88 |
Modality of failure following resection of stage I and stage II non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 164-165 2 p. |
artikel |
89 |
Molecular and biological factors in the prognosis of non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 161- 1 p. |
artikel |
90 |
Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer
|
Pérol, M. |
|
1996 |
14 |
1 |
p. 119-134 16 p. |
artikel |
91 |
N-acetylcysteine (NAC) and glutathione (GSH): Antioxidant and chemopreventive properties, with special reference to lung cancer
|
|
|
1996 |
14 |
1 |
p. 152- 1 p. |
artikel |
92 |
Nd YAG laser and brachytherapy in the treatment of lung cancer
|
|
|
1996 |
14 |
1 |
p. 178- 1 p. |
artikel |
93 |
New drugs in the treatment of non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 168- 1 p. |
artikel |
94 |
Occupational risk factors for lung cancer in Tianjin, China
|
|
|
1996 |
14 |
1 |
p. 153- 1 p. |
artikel |
95 |
Osteolytic bone lesions in a patient with idiopathic myelofibrosis and bronchial carcinoma
|
|
|
1996 |
14 |
1 |
p. 158- 1 p. |
artikel |
96 |
Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 172-173 2 p. |
artikel |
97 |
Paclitaxel and ifosfamide: A multicenter phase I study in advanced non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 171- 1 p. |
artikel |
98 |
Paclitaxel by 1-hour infusion in combination chemotherapy of stage III non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 171- 1 p. |
artikel |
99 |
Paclitaxel by 24- or 1-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: The Fox Chase Cancer Center experience
|
|
|
1996 |
14 |
1 |
p. 172- 1 p. |
artikel |
100 |
Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)
|
|
|
1996 |
14 |
1 |
p. 167- 1 p. |
artikel |
101 |
Paclitaxel 3-hour infusion given alone and combined with carboplatin: Preliminary results of dose-escalation trials
|
|
|
1996 |
14 |
1 |
p. 170- 1 p. |
artikel |
102 |
Paclitaxel plus carboplatin for advanced lung cancer: Preliminary results of a Vanderbilt university phase II trial-LUN-46
|
|
|
1996 |
14 |
1 |
p. 171-172 2 p. |
artikel |
103 |
p53 and disease progression in patients with non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 161- 1 p. |
artikel |
104 |
p53 and K-ras in radon-associated lung adenocarcinoma
|
|
|
1996 |
14 |
1 |
p. 150- 1 p. |
artikel |
105 |
Patterns of DNA methylation of the parathyroid hormone-related protein gene in human lung carcinoma
|
|
|
1996 |
14 |
1 |
p. 156- 1 p. |
artikel |
106 |
Phase II study of all-trans-retinoic acid and α-interferon in patients with advanced non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 167- 1 p. |
artikel |
107 |
Phase II trial and cost analysis of fazarabine in advanced nonsmall cell carcinoma of the lung: A southwest oncology group study
|
|
|
1996 |
14 |
1 |
p. 169- 1 p. |
artikel |
108 |
Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 171- 1 p. |
artikel |
109 |
Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
|
Shepherd, Frances A. |
|
1996 |
14 |
1 |
p. 135-144 10 p. |
artikel |
110 |
p53 immunostaining in combined type small cell lung cancer. Brief report
|
|
|
1996 |
14 |
1 |
p. 155- 1 p. |
artikel |
111 |
Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988–1992
|
Debevec, Miha |
|
1996 |
14 |
1 |
p. 99-107 9 p. |
artikel |
112 |
P53 polymorphisms and haplotypes in lung cancer
|
|
|
1996 |
14 |
1 |
p. 150- 1 p. |
artikel |
113 |
Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 176-177 2 p. |
artikel |
114 |
Pre-operative chemotherapy for stage IIIa (N2)non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 176- 1 p. |
artikel |
115 |
Prognostic analysis of lung cancer patients with brain metastasis and evaluation of long term survivors
|
|
|
1996 |
14 |
1 |
p. 159- 1 p. |
artikel |
116 |
Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer: An analysis in each pathologic stage
|
|
|
1996 |
14 |
1 |
p. 160- 1 p. |
artikel |
117 |
Prognostic significance of CD44 expression in adenocarcinoma of the lung
|
|
|
1996 |
14 |
1 |
p. 161- 1 p. |
artikel |
118 |
Proliferation markers MIB-1 and PCNA in pulmonary neuroendocrine tumors
|
|
|
1996 |
14 |
1 |
p. 163- 1 p. |
artikel |
119 |
Protective effect of jiaogulan on cellular immunity of the patients with primary lung cancer treated by radiotherapy plus chemotherapy
|
|
|
1996 |
14 |
1 |
p. 156- 1 p. |
artikel |
120 |
Pulmonary function 3–12 months after pneumonectomy, lobectomy or bilobectomy for lung cancer
|
|
|
1996 |
14 |
1 |
p. 165- 1 p. |
artikel |
121 |
Pulmonary scar carcinoma: Report of three cases and review of the literature
|
|
|
1996 |
14 |
1 |
p. 157- 1 p. |
artikel |
122 |
Radiation studies on B cell differentiation marker CD24 SCLC Cluster-4 antigen expressing and non-expressing lung cancer cell lines and mouse fibroblasts
|
|
|
1996 |
14 |
1 |
p. 174- 1 p. |
artikel |
123 |
Radioimmunotherapy of small-cell lung cancer xenografts using 131I-labelled anti-NCAM monoclonal antibody 123C3
|
|
|
1996 |
14 |
1 |
p. 178- 1 p. |
artikel |
124 |
Radiotherapy for lung cancer: Comparison of results 628 patients treated with palliative and radical treatment
|
|
|
1996 |
14 |
1 |
p. 175- 1 p. |
artikel |
125 |
Radiotherapy of lung cancer
|
|
|
1996 |
14 |
1 |
p. 174- 1 p. |
artikel |
126 |
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 164- 1 p. |
artikel |
127 |
Results of various modalities of non-surgical treatment of small cell carcinoma of the lungs
|
|
|
1996 |
14 |
1 |
p. 176- 1 p. |
artikel |
128 |
Risk analysis and long-term survival in patients undergoing extended resection of locally advanced lung cancer
|
|
|
1996 |
14 |
1 |
p. 166- 1 p. |
artikel |
129 |
Risk of lung cancer in pre- and post-menopausal women with ano-genital malignancies
|
|
|
1996 |
14 |
1 |
p. 151- 1 p. |
artikel |
130 |
Role of genetic factors in bronchial cancer. Based upon a case of anaplastic lung carcinoma in identical twins
|
|
|
1996 |
14 |
1 |
p. 150- 1 p. |
artikel |
131 |
Simultaneous use of the PCR-SSCP method and immuno-histochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer
|
|
|
1996 |
14 |
1 |
p. 156- 1 p. |
artikel |
132 |
Small cell lung cancer with and without superior vena cava syndrome: A multivariate analysis of prognostic factors in 408 cases
|
|
|
1996 |
14 |
1 |
p. 160- 1 p. |
artikel |
133 |
Somatic genetic changes in lung cancer and precancerous lesions
|
|
|
1996 |
14 |
1 |
p. 150- 1 p. |
artikel |
134 |
Squamous cell carcinoma of the lung with high CT number, but without calcification
|
|
|
1996 |
14 |
1 |
p. 163- 1 p. |
artikel |
135 |
Stage I nonsmall cell lung cancer: A multivariate analysis of treatment methods and patterns of recurrence
|
|
|
1996 |
14 |
1 |
p. 165- 1 p. |
artikel |
136 |
Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer
|
|
|
1996 |
14 |
1 |
p. 173-174 2 p. |
artikel |
137 |
Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: Detection by reverse transcriptase-polymerase chain reaction
|
|
|
1996 |
14 |
1 |
p. 155- 1 p. |
artikel |
138 |
Surgical treatment of lung cancer in patients with human immunodeficiency virus
|
|
|
1996 |
14 |
1 |
p. 166- 1 p. |
artikel |
139 |
Surgical treatment of non-small cell lung carcinoma in TNM stage IIIA
|
|
|
1996 |
14 |
1 |
p. 166- 1 p. |
artikel |
140 |
Survival in early-stage non-small cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 160- 1 p. |
artikel |
141 |
Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer
|
|
|
1996 |
14 |
1 |
p. 163- 1 p. |
artikel |
142 |
The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy
|
|
|
1996 |
14 |
1 |
p. 174-175 2 p. |
artikel |
143 |
The close relationship between growth factors and the nucleolar organizer regions in adenocarcinoma of the lung
|
|
|
1996 |
14 |
1 |
p. 156- 1 p. |
artikel |
144 |
The early detection of pleural dissemination of lung cancer by thin-slice computed tomography
|
|
|
1996 |
14 |
1 |
p. 159- 1 p. |
artikel |
145 |
The economics of lung cancer
|
Boyer, Michael |
|
1996 |
14 |
1 |
p. 13-17 5 p. |
artikel |
146 |
The economics of lung cancer management in Canada
|
Evans, W.K. |
|
1996 |
14 |
1 |
p. 19-29 11 p. |
artikel |
147 |
The effectiveness of transthoracic biopsy in diagnosis and treatment of neoplasms of chest organs
|
|
|
1996 |
14 |
1 |
p. 161- 1 p. |
artikel |
148 |
The influence of radiation and nonradiation factors on the lung cancer incidence among the workers of the nuclear enterprise Mayak
|
|
|
1996 |
14 |
1 |
p. 149- 1 p. |
artikel |
149 |
The peculiarities of metastatic spreading of lung cancer in cases of hereditary-related incidence
|
|
|
1996 |
14 |
1 |
p. 161- 1 p. |
artikel |
150 |
The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy
|
|
|
1996 |
14 |
1 |
p. 157-158 2 p. |
artikel |
151 |
The surgery of lung cancer
|
|
|
1996 |
14 |
1 |
p. 166- 1 p. |
artikel |
152 |
The treatment of patients with recurrent brain metastases: A retrospective analysis of 109 patients with nonsmall cell lung cancer
|
|
|
1996 |
14 |
1 |
p. 162- 1 p. |
artikel |
153 |
The tumour marker ‘Neuron-Specific enolase’ as prognosis indicator in small-cell bronchial carcinoma
|
|
|
1996 |
14 |
1 |
p. 160- 1 p. |
artikel |
154 |
The usefulness of the nebulization chemotherapy in the treatment of lung cancer
|
|
|
1996 |
14 |
1 |
p. 172- 1 p. |
artikel |
155 |
Urinary cotinine and lung cancer risk in a female cohort
|
|
|
1996 |
14 |
1 |
p. 151- 1 p. |
artikel |
156 |
Urinary nicotine metabolite excretion and lung cancer risk in a female cohort
|
|
|
1996 |
14 |
1 |
p. 151- 1 p. |
artikel |